Pharma Marketing Network

This morning I was treated to a confluence of stories that intertwine in interesting ways -- something that always prompts me to point out...

Let's try a few of these and see how far we get in the real world:

There's been a lot of angst over an increase in FDA enforcement letters and the effect they might have on the bottom line. Mostly,...

I'm leading a panel discussion at an upcoming conference that will soon be announced. The panel will feature several people who I met at...

Long before there was a Hanna Montana there was a Wanda Nevada -- a 1979 movie starring Brooke Shields and Peter Fonda. I saw...

The recent FDA Draft Guidance for Industry, Presenting Risk Information in Prescription Drug and Medical Device Promotion guidance focuses almost exclusively on print and broadcast promotional ads. It is possible, however, to apply some of FDA's

Each pharmaceutical company should have its own guidelines for best practices in the social media space. To assist in that discussion, Pharma Marketing News hosted a survey to explores issue relating to pharma advertising and engagement in social networks. This article summarizes the results of that survey.

This article focuses in some detail on three interesting pharma social media initiatives: (1) Procter & Gamble's Asacol Community for Ulcerative Colitis Patients; (2) Novo Nordisk's Levemir-branded Race With Insulin Twitter account; and (3) UCB's sponsored epilepsy community on the PatientsLikeMe website.

Welcome to the June/July 2009 issue of Pharma Marketing News.

GSK Blogs About Challenges of Communicating via New Media Channels"Michael F," writing on GSK's More than Medicine Blog, suggests that critics "take into consideration...